Brokers name 3 ASX shares to buy now

Here's why brokers are feeling bullish about these three shares this week.

| More on:
A man sits in deep thought with a pen held to his lips as he ponders his computer screen with a laptop open next to him on his desk in a home office environment.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It has been another busy week for many of Australia's top brokers. This has led to the release of a number of broker notes.

Three broker buy ratings that you might want to know more about are summarised below. Here's why brokers think these ASX shares are in the buy zone right now:

Baby Bunting Group Ltd (ASX: BBN)

According to a note out of Morgans, its analysts have retained their add rating on this baby products retailer's shares with an improved price target of $1.80. This follows the release of a trading update this week which saw the company reaffirm its profit guidance for FY 2024. However, the big positive was the improvement in the company's sales performance since the end of April. It feels this bodes well for Baby Bunting in FY 2025. So much so, it is forecasting a huge rebound its profits. In addition, Morgans notes that its medium term growth will be supported by new exclusive supply agreements. The Baby Bunting share price is trading at $1.57 on Friday afternoon.

Universal Store Holdings Ltd (ASX: UNI)

A note out of UBS reveals that its analysts have upgraded this youth fashion retailer's shares to a buy rating with a $6.00 price target. The broker made the move largely on valuation grounds following a recent pullback in the company's share price. Outside this, it likes Universal Store due to its exposure to the resilient youth consumer and its successful marketing execution. And while its store rollout may be slower than originally hoped, it appears to see positives in this approach. UBS also highlights its strong balance sheet and positive medium term growth outlook as reasons to buy its shares. The Universal Store share price is fetching $4.96 at the time of writing.

Woolworths Group Ltd (ASX: WOW)

Analysts at Goldman Sachs have reiterated their buy rating on this supermarket giant's shares with an improved price target of $40.20. The broker believes that concerns over margin weakness and regulatory reviews is overdone and created a buying opportunity for investors. In respect to margins, Goldman's analysis and channel checks suggest resilient ~3% industry topline supermarket growth from improving volume. In addition, it sees ample levers for gross profit margin expansion through business model mix and margin optimisation opportunities. As a result, Goldman is forecasting an earnings per share compound annual growth rate of 8.2% between FY 2024 and FY 2027. The Woolworths share price is trading at $33.87 this afternoon.

Motley Fool contributor James Mickleboro has positions in Universal Store. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Broker Notes

These ASX shares could rise 25% to 30%

Big returns could be on offer with these shares according to analysts.

Read more »

Two male professional analysts discuss share price movements shown on the computer screen in front of them, with one pointing to a screen
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Four people gather around laptop and cheer
Broker Notes

3 of the best ASX 200 stocks to buy in FY25

Big returns and buy ratings. That's what Bell Potter is saying about these shares.

Read more »

Research, collaboration and doctors working digital tablet, analysis and discussion of innovation cancer treatment. Healthcare, teamwork and planning by experts sharing idea and strategy for surgery.
Healthcare Shares

'Obvious buying opportunity': Top broker says beaten-up ASX All Ords stock has 253% upside

Wilsons analysts say the market has misread top-line medical trial results released this week.

Read more »

Senior woman using cpap machine to stop choking and snoring from obstructive sleep apnoea with bokeh and morning light background.
Broker Notes

Should you pounce on ResMed shares at around $28?

Here's what top broker Citi says.

Read more »

Three people in a corporate office pour over a tablet, ready to invest.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

ANZ ASX 200 banks capital return Group of investors madly grabbing for cash on city street.
Healthcare Shares

ResMed shares rebounding as investors rush to buy the dip

ResMed is rising as ASX investors buy the dip following yesterday's 13% share price dive.

Read more »

A group of stockbrokers sit in a room with several computer screens in front of them as they discuss the Zip share price and Zip's merger with Sezzle
Broker Notes

Why these 3 ASX 200 shares just gained significant broker upgrades

The brokers just boosted their outlooks for these ASX 200 shares. But why?

Read more »